Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.

Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.

Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) RIG-1 (also known as DDX58) binding to viral RNA.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.

The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.

The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.

Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.

Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta secretion.

Any process that activates or increases the frequency, rate, or extent of interferon-beta secretion.

Any series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA. MDA-5 detects RNA synthesized during active viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.

Any series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA. MDA-5 detects RNA synthesized during active viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) RIG-1 (also known as DDX58) binding to viral RNA.

Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.

Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.

Reactions triggered in response to the presence of a virus that act to protect the cell or organism.

Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.

Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.

Any process that activates or increases the frequency, rate or extent of MDA-5 signaling pathway.

Any process that activates or increases the frequency, rate or extent of RIG-I signaling pathway.

Any immune response that is involved in response to exogenous dsRNA.

Any process that activates or increases the frequency, rate or extent of interferon-alpha secretion.

Any process that activates or increases the frequency, rate or extent of interferon-alpha secretion.

Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.

Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.

Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.

Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.

The series of events in which a stimulus from a virus is received and converted into a molecular signal.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.

The removal of one or more ubiquitin groups from a protein.

The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.

Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.

Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta production.

Any process that activates or increases the frequency, rate, or extent of interferon-beta production.

Any process that modulates the frequency, rate, or extent of type III interferon production. Interferon lambda is the only member of the type III interferon found so far.

Any process that activates or increases the frequency, rate, or extent of interferon-beta secretion.

Any series of molecular signals generated as a consequence of a virus or viral RNA binding to a pattern recognition receptor (PRR) located in the cytoplasm. Cytosolic PRRs such as RIG-I (DDX58) and MDA-5 (IFIH1) detect RNA synthesized during active viral replication and trigger a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.

Any series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA. MDA-5 detects RNA synthesized during active viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) MDA-5 (also known as IFIH1) binding to viral RNA.

Any process that stops, prevents, or reduces the frequency, rate or extent of the series of molecular signals generated as a consequence of the cytoplasmic pattern recognition receptor (PRR) RIG-1 (also known as DDX58) binding to viral RNA.

Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.

Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.

Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.

Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.

Reactions triggered in response to the presence of a virus that act to protect the cell or organism.

Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.

Any process that activates or increases the frequency, rate or extent of MDA-5 signaling pathway.

Any process that activates or increases the frequency, rate or extent of RIG-I signaling pathway.

Any process that activates or increases the frequency, rate or extent of interferon-alpha secretion.

Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.

Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.